The association between metformin and head and neck cancer survival: a systematic review and meta-analysis of cohort studies.

CONCLUSION: In this meta-analysis of 7 retrospective cohort studies, there was not a statistically significant association between use of metformin and better survival for head and neck cancer. However, the analysis may have been underpowered. More studies of prospective designs with larger sample sizes are needed to investigate the effect of metformin on the survival for head and neck cancer. PMID: 32067604 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Tags: Curr Pharm Des Source Type: research